Cargando…
Recombinant soluble CCR5 AND CXCR4 chemokine receptors as anti-HIV drug targets
Autores principales: | Kurbatska, Victoria, Rudevica, Zhanna, Tsimanis, Alexander, Leonciks, Ainars |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316044/ http://dx.doi.org/10.1186/1742-4690-7-S1-P44 |
Ejemplares similares
-
Upregulation of the Chemokine Receptor CCR2B in Epstein‒Barr Virus-Positive Burkitt Lymphoma Cell Lines with the Latency III Program
por: Kozireva, Svetlana, et al.
Publicado: (2018) -
Sorting out the Superbugs: Potential of Sortase A Inhibitors among Other Antimicrobial Strategies to Tackle the Problem of Antibiotic Resistance
por: Zrelovs, Nikita, et al.
Publicado: (2021) -
Expression of the Chemokine Receptor CCR1 in Burkitt Lymphoma Cell Lines Is Linked to the CD10-Negative Cell Phenotype and Co-Expression of the EBV Latent Genes EBNA2, LMP1, and LMP2
por: Zvejniece, Laura, et al.
Publicado: (2022) -
Macrocyclic polyamines inhibit HIV infection by interacting with the cellular HIV co-receptors CXCR4 and CCR5
por: Schols, Dominique, et al.
Publicado: (2009) -
Induction of molecular remission by using anti-CC-chemokine receptor 4 (anti-CCR4) antibodies for adult T-cell leukemia: a risk of opportunistic infection after treatment with anti-CCR4 antibodies
por: Maeda, Yasuhiuro, et al.
Publicado: (2014)